基本信息
浏览量:325
职业迁徙
个人简介
Dr. Hisataka Kobayashi is the chief scientist in the Molecular Imaging Program at the National Cancer Institute/ NIH in Bethesda, MD. Dr. Kobayashi was awarded MD in 1987 and PhD (Immunology/Medicine) in 1995 from the Kyoto University, Kyoto, Japan. His interest is in developing the novel molecular imaging and therapeutic agents or technologies especially for targeting cancers. He has published over 250 scientific articles in clinical and preclinical bio-medical imaging over the last 20 years.
研究兴趣
论文共 457 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hiroshi Fukushima,Aki Furusawa,Seiichiro Takao,Siddharth S. Matikonda, Makoto Kano,Shuhei Okuyama, Hiroshi Yamamoto,Peter L. Choyke,Martin J. Schnermann,Hisataka Kobayashi
eBioMedicine (2024): 105050-105050
Hiroshi Fukushima,Seiichiro Takao,Aki Furusawa, Vladimir Valera Romero,Sandeep Gurram,Takuya Kato,Shuhei Okuyama, Makoto Kano,Peter L. Choyke,Hisataka Kobayashi
CANCER LETTERS (2024): 216606-216606
Teruki Kobayashi,Kazuhiro Noma,Seitaro Nishimura,Takuya Kato, Noriyuki Nishiwaki,Toshiaki Ohara,Tomoyoshi Kunitomo,Kento Kawasaki, Masaaki Akai,Satoshi Komoto,Hajime Kashima,Satoru Kikuchi,
Molecular cancer therapeutics (2024)
Hiroshi Fukushima,Aki Furusawa,Seiichiro Takao,Siddharth S. Matikonda, Makoto Kano,Shuhei Okuyama, Hiroshi Yamamoto,Peter L. Choyke,Martin J. Schnermann,Hisataka Kobayashi
EBioMedicine (2024): 105050
引用0浏览0引用
0
0
Seiichiro Takao,Aki Furusawa,Hiroshi Fukushima,Shuhei Okuyama, Makoto Kano, Hiroshi Yamamoto,Peter L. Choyke,Hisataka Kobayashi
Cancer Researchno. 6_Supplement (2024): 5971-5971
Masaaki Akai,Kazuhiro Noma,Takuya Kato,Seitaro Nishimura, Hijiri Matsumoto,Kento Kawasaki,Tomoyoshi Kunitomo, Teruki Kobayashi,Noriyuki Nishiwaki,Hajime Kashima,Satoru Kikuchi,Toshiaki Ohara,
crossref(2023)
crossref(2023)
crossref(2023)
Cancersno. 21 (2023): 5117-5117
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn